Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Budget-Impact Analysis of Health Care Interventions

A Practical Guide - Previously published in hardcover
BuchKartoniert, Paperback
224 Seiten
Englisch
Springererschienen am13.05.2018Softcover reprint of the original 1st ed. 2017
The first of its kind for budget-impact analysis, this comprehensive guide provides clear and concise instructions for evaluating the impact that new pharmaceuticals will have on the budget for a specific jurisdiction.mehr
Verfügbare Formate
BuchGebunden
EUR128,39
BuchKartoniert, Paperback
EUR90,94
E-BookPDF1 - PDF WatermarkE-Book
EUR90,94

Produkt

KlappentextThe first of its kind for budget-impact analysis, this comprehensive guide provides clear and concise instructions for evaluating the impact that new pharmaceuticals will have on the budget for a specific jurisdiction.
Details
ISBN/GTIN978-3-319-84408-4
ProduktartBuch
EinbandartKartoniert, Paperback
Verlag
Erscheinungsjahr2018
Erscheinungsdatum13.05.2018
AuflageSoftcover reprint of the original 1st ed. 2017
Seiten224 Seiten
SpracheEnglisch
Gewicht421 g
IllustrationenXVIII, 224 p. 30 illus., 3 illus. in color.
Artikel-Nr.46143893
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
1. Introduction to Budget-Impact Analysis.- 2. Determining the Analytic Framework.- 3. Estimating the Diagnosed, Treated, and Eligible Population.- 4. Estimating the Treatment Mix.- 5. Estimating Treatment-Related Costs.- 6. Estimating Condition-Related Costs.- 7. The Computing Framework and Calculations.- 8. Uncertainty Analysis.- 9. Validation.- 10. Software and Computer Interface.- 11. Reporting Budget-Impact Analyses.- 12. Additional Pragmatic Topics.- 13. Alternative Interventions.- 14. Creating Your Own Budget-Impact Analyses Today and Tomorrow.mehr

Schlagworte

Autor

Josephine A. Mauskopf, PhD, MHA, MA

Josephine Mauskopf is Vice President of Health Economics at RTI Health Solutions. She has been on the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Board of Directors and was co-chair of the first and second ISPOR Task Force for budget-impact analysis. Dr. Mauskopf was Department Head of Economics Research at Burroughs Wellcome Co. and Director of Pharmacoeconomics Research for Anti-Virals and Anti-Infectives at Glaxo Wellcome Inc.

Her research interest is in designing and implementing pharmacoeconomic research strategies and programs for the pharmaceutical industry.

She has published over 100 articles and written an encyclopedia entry for budget-impact analysis. She has served as Editor-in-Chief of Value in Health and is an Associate Editor for Medical Decision Making. Dr. Mauskopf was also the recipient of the 2013 Avedis Donabedian Lifetime Achievement Award.

Stephanie R.Earnshaw, PhD, MS

Stephanie Earnshaw is Senior Vice President of Health Economics at RTI Health Solutions. She has also had an adjunct professor appointment in the University of North Carolina (UNC) Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy. Prior to joining RTI Health Solutions, Dr. Earnshaw worked in UNC's School of Public Health as the Operations Director of the Survey Research Unit and taught courses in the Kenan-Flagler Business School.

Her research interest is primarily in applying decision analytic techniques to novel pharmacoeconomic and outcomes research problems for the pharmaceutical industry.
She has published 47 articles and has written 3 book chapters. She has taught short courses and distance learning courses for the International Society for Pharmacoeconomics and Outcome Research and is on the editorial board of PharmacoEconomics - Open.
Weitere Artikel von
Mauskopf, Josephine
Weitere Artikel von
Earnshaw, Stephanie R.
Weitere Artikel von
Brogan, Anita